SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-08-002220
Filing Date
2008-04-01
Accepted
2008-04-01 17:28:54
Documents
6
Period of Report
2008-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BENTLEY PHARMACEUTICALS b69449bpe8vk.htm 8-K 29371
2 EX-4.1 - AMENDMENT NO. 1 TO RENEWAL RIGHTS AGREEMENT b69449bpexv4w1.htm EX-4.1 22619
3 EX-10.1 - AGREEMENT AND PLAN OF MERGER b69449bpexv10w1.htm EX-10.1 341574
4 EX-99.1 - PRESS RELEASE DATED MARCH 31, 2007 b69449bpexv99w1.htm EX-99.1 20146
5 GRAPHIC b69449bpb6944902.gif GRAPHIC 6251
6 GRAPHIC b69449bpb6944901.gif GRAPHIC 4858
  Complete submission text file 0000950135-08-002220.txt   431026
Mailing Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833
Business Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833 6036586100
BENTLEY PHARMACEUTICALS INC (Filer) CIK: 0000821616 (see all company filings)

IRS No.: 591513162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10581 | Film No.: 08730512
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1